Alopecia Areata Following the Use of Belimumab in a Patient with Systemic Lupus Erythematosus and Arthritis Who Responded Well to Baricitinib: A Case Report

    October 2024 in “ American Journal of Case Reports
    Hani Almoallim, Maryam Dahlawi, Mutasem Abed, Rasha Alamr
    Image of study
    TLDR Baricitinib improved hair loss and arthritis in a lupus patient.
    This case report discusses a 54-year-old Saudi female with systemic lupus erythematosus (SLE) who developed alopecia areata (AA) progressing to alopecia totalis (AT) and alopecia universalis (AU) after treatment with belimumab. Despite initial improvements with belimumab, her hair loss worsened, and steroid treatments were only partially effective. After discontinuing belimumab and switching to baricitinib, significant improvement in both AT and arthritis was observed. The report suggests that baricitinib's effectiveness in SLE warrants further investigation, highlighting the need for research focused on specific outcomes rather than composite measures.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    1 / 1 results